SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma

Overview of attention for article published in Cancer (0008543X), December 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 30,197 followers.

RT @JournalCancer: SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma https://t.co/HrooS…

SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma https://t.co/HrooSaOvYS

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.